Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
2.
Biochemistry ; 40(7): 2052-9, 2001 Feb 20.
Article in English | MEDLINE | ID: mdl-11329272

ABSTRACT

Eosinophils use eosinophil peroxidase, hydrogen peroxide (H(2)O(2)), and bromide ion (Br(-)) to generate hypobromous acid (HOBr), a brominating intermediate. This potent oxidant may play a role in host defenses against invading parasites and eosinophil-mediated tissue damage. In this study, we explore the possibility that HOBr generated by eosinophil peroxidase might oxidize nucleic acids. When we exposed uracil, uridine, or deoxyuridine to reagent HOBr, each reaction mixture yielded a single major oxidation product that comigrated on reversed-phase HPLC with the corresponding authentic brominated pyrimidine. The eosinophil peroxidase-H(2)O(2)-Br(-) system also converted uracil into a single major oxidation product, and the yield was near-quantitative. Mass spectrometry, HPLC, UV--visible spectroscopy, and NMR spectroscopy identified the product as 5-bromouracil. Eosinophil peroxidase required H(2)O(2) and Br(-) to produce 5-bromouracil, implicating HOBr as an intermediate in the reaction. Primary and secondary bromamines also brominated uracil, suggesting that long-lived bromamines also might be physiologically relevant brominating intermediates. Human eosinophils used the eosinophil peroxidase-H(2)O(2)-Br(-) system to oxidize uracil. The product was identified as 5-bromouracil by mass spectrometry, HPLC, and UV--visible spectroscopy. Collectively, these results indicate that HOBr generated by eosinophil peroxidase oxidizes uracil to 5-bromouracil. Thymidine phosphorylase, a pyrimidine salvage enzyme, transforms 5-bromouracil to 5-bromodeoxyridine, a mutagenic analogue of thymidine. These findings raise the possibility that halogenated nucleobases generated by eosinophil peroxidase exert cytotoxic and mutagenic effects at eosinophil-rich sites of inflammation.


Subject(s)
Bromides/metabolism , Bromouracil/metabolism , Eosinophils/enzymology , Hydrogen Peroxide/metabolism , Mutagens/metabolism , Peroxidases/metabolism , Sodium Compounds/metabolism , Bromates/metabolism , Bromides/blood , Bromine/chemistry , Bromine/metabolism , Bromodeoxyuridine/metabolism , Catalase/antagonists & inhibitors , Catalase/metabolism , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Eosinophil Peroxidase , Eosinophils/metabolism , Humans , Hydrogen-Ion Concentration , Peroxidases/antagonists & inhibitors , Pyrimidines/chemistry , Sodium Compounds/blood , Thymidine Phosphorylase/metabolism , Uracil/metabolism
3.
J Biol Chem ; 276(11): 7867-75, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11096071

ABSTRACT

The existence of interhalogen compounds was proposed more than a century ago, but no biological roles have been attributed to these highly oxidizing intermediates. In this study, we determined whether the peroxidases of white blood cells can generate the interhalogen gas bromine chloride (BrCl). Myeloperoxidase, the heme enzyme secreted by activated neutrophils and monocytes, uses H2O2 and Cl(-) to produce HOCl, a chlorinating intermediate. In contrast, eosinophil peroxidase preferentially converts Br(-) to HOBr. Remarkably, both myeloperoxidase and eosinophil peroxidase were able to brominate deoxycytidine, a nucleoside, and uracil, a nucleobase, at plasma concentrations of Br(-) (100 microM) and Cl(-) (100 mM). The two enzymes used different reaction pathways, however. When HOCl brominated deoxycytidine, the reaction required Br(-) and was inhibited by taurine. In contrast, bromination by HOBr was independent of Br(-) and unaffected by taurine. Moreover, taurine inhibited 5-bromodeoxycytidine production by the myeloperoxidase-H2O2-Cl(-)- Br(-) system but not by the eosinophil peroxidase-H2O2-Cl(-)-Br(-) system, indicating that bromination by myeloperoxidase involves the initial production of HOCl. Both HOCl-Br(-) and the myeloperoxidase-H2O2-Cl(-)-Br(-) system generated a gas that converted cyclohexene into 1-bromo-2-chlorocyclohexane, implicating BrCl in the reaction. Moreover, human neutrophils used myeloperoxidase, H2O2, and Br(-) to brominate deoxycytidine by a taurine-sensitive pathway, suggesting that transhalogenation reactions may be physiologically relevant. 5-Bromouracil incorporated into nuclear DNA is a well known mutagen. Our observations therefore raise the possibility that transhalogenation reactions initiated by phagocytes provide one pathway for mutagenesis and cytotoxicity at sites of inflammation.


Subject(s)
Bromine/metabolism , Deoxycytidine/metabolism , Inflammation/metabolism , Mutagens/metabolism , Peroxidase/metabolism , Uracil/metabolism , Bromouracil/metabolism , DNA Damage , Humans , Hydrogen Peroxide/metabolism , Hypochlorous Acid/metabolism , Inflammation/complications , Neutrophils/metabolism , Oxidation-Reduction
4.
J Biol Chem ; 276(11): 8602-7, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11083870

ABSTRACT

The mammalian mitochondrial ATP synthase is composed of at least 16 polypeptides. With the exception of coupling factor F(6), there are likely yeast homologs for each of these polypeptides. There are no obvious yeast homologs of F(6), as predicted from primary sequence comparison of the putative peptides encoded by the open reading frames in the yeast genome. In this manuscript, we demonstrate that expression of bovine F(6) complements a null mutant in ATP14 gene in yeast Saccharomyces cerevisiae. Subunit h of the yeast ATP synthase is encoded by ATP14 and is just 14.5% identical to bovine F(6). Expression of bovine F(6) in an atp14 null mutant strain recovers oxidative phosphorylation, and the ATP synthase is active, although functioning with a lower efficiency than the wild type enzyme. Like subunit h, bovine F(6) is shown to interact mainly with subunit 4 (subunit b), a component of the second stalk of the enzyme. These data indicated the subunit h is the yeast homolog of mammalian coupling factor F(6).


Subject(s)
Adenosine Triphosphatases/chemistry , Mitochondrial Proton-Translocating ATPases , Oxidative Phosphorylation Coupling Factors , Proton-Translocating ATPases/chemistry , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Animals , Cattle , Molecular Sequence Data , Protein Subunits , Proton-Translocating ATPases/genetics
5.
Eur J Biochem ; 267(8): 2409-18, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10759867

ABSTRACT

The F1F0 ATP synthase is composed of the F1-ATPase which is bound to F0, in the inner membrane of the mitochondrion. Assembly and function of the enzyme is a complicated task requiring the interactions of many proteins for the folding, import, assembly, and function of the enzyme. The F1-ATPase is a multimeric enzyme composed of five subunits in the stoichiometry of alpha3beta3gammadeltaepsilon. This study demonstrates that four of the five bovine subunits of the F1-ATPase can be imported and function in an otherwise yeast enzyme effectively complementing mutations in the genes encoding the corresponding yeast ATPase subunits. In order to demonstrate this, the coding regions of each of the five genes were separately deleted in yeast providing five null mutant strains. All of the strains displayed negative or a slow growth phenotype on medium containing glycerol as the carbon source and strains with a null mutation in the gene encoding the gamma-, delta- or epsilon-gene became completely, or at a high frequency, cytoplasmically petite. The subunits of bovine F1 were expressed individually in the yeast strains with the corresponding null mutations and targeted to the mitochondrion using a yeast mitochondrial leader peptide. Expression of the bovine alpha-, beta-, gamma-, and epsilon-, but not the delta-, subunit complemented the corresponding null mutations in yeast correcting the corresponding negative phenotypes. These results indicate that yeast is able to import, assemble subunits of bovine F1-ATPase in mitochondria and form a functional chimeric yeast/bovine enzyme complex.


Subject(s)
Genetic Complementation Test , Proton-Translocating ATPases/genetics , Saccharomyces cerevisiae/enzymology , Animals , Cattle , Cell Division/genetics , Gene Expression Regulation, Enzymologic/genetics , Mitochondria/enzymology , Multienzyme Complexes/genetics , Mutation , Phenotype , Protein Sorting Signals/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/genetics
6.
J Biol Chem ; 275(10): 6963-8, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10702258

ABSTRACT

Prior genetic studies indicated that the yeast mitochondrial ATP synthase can be assembled into enzyme complexes devoid of the gamma-, delta-, or epsilon-subunits (Lai-Zhang, J., Xiao, Y., and Mueller, D. M. (1999) EMBO J. 18, 58-64). These subunit-deficient complexes were postulated to uncouple the mitochondrial membrane thereby causing negative cellular phenotypes. This study provides biochemical and additional genetic data that support this hypothesis. The genetic data indicate that in a diploid cell, a heterozygous deletion mutation in the gene encoding the gamma- or delta-subunit of the ATPase is semidominant negative due to a decrease in the gene number from 2 to 1. However, the heterozygous atp2Delta mutation is epistatic to the heterozygous mutation in the gene encoding gamma or delta, suggesting that the semidominant negative effect is because of a gain of activity in the cells. Biochemical studies using mitochondria isolated from the yeast strains that are heterozygous for a mutation in gamma or delta indicate that the mitochondria are partially uncoupled. These results support the hypothesis that the negative phenotypes are caused by the formation of a gamma- or delta-less ATP synthase complex that is uncoupled.


Subject(s)
Adenosine Triphosphatases/physiology , Mitochondria/enzymology , Saccharomyces cerevisiae/enzymology , Adenosine Triphosphatases/genetics , Cell Membrane/metabolism , Heterozygote , Mutation , Oxygen Consumption
7.
J Bioenerg Biomembr ; 32(4): 391-400, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11768301

ABSTRACT

The mitochondrial ATP synthase is a molecular motor that drives the phosphorylation of ADP to ATP. The yeast mitochondrial ATP synthase is composed of at least 19 different peptides, which comprise the F1 catalytic domain, the F0 proton pore, and two stalks, one of which is thought to act as a stator to link and hold F1 to F0, and the other as a rotor. Genetic studies using yeast Saccharomyces cerevisiae have suggested the hypothesis that the yeast mitochondrial ATP synthase can be assembled in the absence of 1, and even 2, of the polypeptides that are thought to comprise the rotor. However, the enzyme complex assembled in the absence of the rotor is thought to be uncoupled, allowing protons to freely flow through F0 into the mitochondrial matrix. Left uncontrolled, this is a lethal process and the cell must eliminate this leak if it is to survive. In yeast, the cell is thought to lose or delete its mitochondrial DNA (the petite mutation) thereby eliminating the genes encoding essential components of F0. Recent biochemical studies in yeast, and prior studies in E. coli, have provided support for the assembly of a partial ATP synthase in which the ATP synthase is no longer coupled to proton translocation.


Subject(s)
Mitochondria/enzymology , Proton-Translocating ATPases/genetics , Saccharomyces cerevisiae/enzymology , Mutagenesis , Protein Subunits , Proton-Translocating ATPases/chemistry , Proton-Translocating ATPases/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Deletion
8.
FEBS Lett ; 455(3): 243-6, 1999 Jul 23.
Article in English | MEDLINE | ID: mdl-10437781

ABSTRACT

Myeloperoxidase, a heme protein secreted by activated phagocytes, is present and enzymatically active in human atherosclerotic lesions. In the current studies, we explored the possibility that reactive nitrogen species generated by myeloperoxidase promote lipid peroxidation of low density lipoprotein (LDL) -- a modification that may render the lipoprotein atherogenic. We found that myeloperoxidase, an H2O2-generating system and nitrite (NO2-) peroxidized LDL lipids. The process required NO2- and each component of the enzymatic system; it was inhibited by catalase, cyanide and ascorbate, a potent scavenger of aqueous phase radicals. LDL peroxidation did not require chloride ion, and it was little affected by the hypochlorous acid scavenger taurine. Collectively, these results suggest that lipid peroxidation is promoted by a nitrogen dioxide radical-like species. These observations indicate that myeloperoxidase, by virtue of its ability to form reactive nitrogen intermediates, may promote lipid peroxidation and atherogenesis.


Subject(s)
Lipid Peroxidation/physiology , Lipoproteins, LDL/metabolism , Nitrogen Dioxide/metabolism , Peroxidase/metabolism , Antioxidants/pharmacology , Arteriosclerosis/enzymology , Arteriosclerosis/etiology , Ascorbic Acid/pharmacology , Free Radicals/metabolism , HL-60 Cells , Humans , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , Nitrites/metabolism , Probucol/pharmacology , Vitamin E/pharmacology
9.
J Bioenerg Biomembr ; 31(2): 95-104, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10449236

ABSTRACT

The crystal structure of mitochondrial F1-ATPase indicates that the alpha and beta subunits fold into a structure defined by three domains: the top beta-barrel domain, the middle nucleotide-binding domain, and the C-terminal alpha-helix bundle domain (Abrahams et al., 1994); Bianchet et al., 1998). The beta-barrel domains of the alpha and beta subunits form a crown structure at the top of F1, which was suggested to stabilize it (Abrahams et al. 1994). In this study, the role of the beta-barrel domain in the alpha and beta subunits of the yeast Saccharomyces cerevisiae F1, with regard to its folding and assembly, was investigated. The beta-barrel domains of yeast F1alpha and beta subunits were expressed individually and together in Escherichia coli. When expressed separately, the beta-barrel domain of the beta subunit formed a large aggregate structure, while the domain of the alpha subunit was predominately a monomer or dimer. However, coexpression of the beta-barrel domain of alpha subunit with the beta-barrel domain of beta subunit, greatly reduced the aggregation of the beta subunit domain. Furthermore, the two domains copurified in complexes with the major portion of the complex found in a small molecular weight form. These results indicate that the beta-barrel domain of the alpha and beta subunits interact specifically with each other and that these interactions prevent the aggregation of the beta-barrel domain of the beta subunit. These results mimic in vivo results and suggest that the interactions of the beta-barrel domains may be critical during the folding and assembly of F1.


Subject(s)
Mitochondria/enzymology , Proton-Translocating ATPases/chemistry , Proton-Translocating ATPases/metabolism , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Animals , Cattle , Cloning, Molecular , Escherichia coli , Macromolecular Substances , Molecular Sequence Data , Molecular Weight , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Polymerase Chain Reaction , Protein Structure, Secondary , Proton-Translocating ATPases/isolation & purification , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid
10.
J Biol Chem ; 274(23): 16363-9, 1999 Jun 04.
Article in English | MEDLINE | ID: mdl-10347195

ABSTRACT

The first 90 amino acids of the alpha- and beta-subunits of mitochondrial F1-ATPase are folded into beta-barrel domains and were postulated to be important for stabilizing the enzyme (Abrahams, J. P., Leslie, A. G., Lutter, R., and Walker, J. E. (1994) Nature 370, 621-628). The role of the domains was studied by making chimeric enzymes, replacing the domains from the yeast Saccharomyces cerevisiae enzyme with the corresponding domains from the enzyme of the thermophilic bacterium Bacillus PS3. The enzymes containing the chimeric alpha-, beta-, or alpha- and beta-subunits were not functional. However, gain-of-function mutations were obtained from the strain containing the enzyme with the chimeric PS3/yeast beta-subunit. The gain-of-function mutations were all in codons encoding the beta-barrel domain of the beta-subunit, and the residues appear to map out a region of subunit-subunit interactions. Gain-of-function mutations were also obtained that provided functional expression of the chimeric PS3/yeast alpha- and beta-subunits together. Biochemical analysis of this active chimeric enzyme indicated that it was not significantly more thermostable or labile than the wild type. The results of this study indicate that the beta-barrel domains form critical contacts (distinct from those between the alpha- and beta-subunits) that are important for the assembly of the ATP synthase.


Subject(s)
Proton-Translocating ATPases/chemistry , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Blotting, Western , Models, Molecular , Molecular Sequence Data , Protein Conformation , Protein Folding , Protein Structure, Secondary , Proton-Translocating ATPases/metabolism , Sequence Homology, Amino Acid , Structure-Activity Relationship
11.
Prev Med ; 28(5): 510-9, 1999 May.
Article in English | MEDLINE | ID: mdl-10329342

ABSTRACT

BACKGROUND: This study was designed to test different ways of meeting the new ACSM/CDC recommendations for physical activity stating that all Americans at least 2 years of age should obtain 30 minutes of moderate intensity activity on most days of the week. METHODS: Thirty-two sedentary 18- to 55-year-old adults were randomly assigned to three groups of brisk walking/6 days per week: 30 continuous minutes, three 10-minute bouts, and 30 minutes in any combination of bouts as long as each bout was at least 5 minutes. Aerobic fitness, blood pressure, body composition, and physical activity were assessed at baseline, at end of program (16 weeks), and at follow-up (32 weeks). RESULTS: All groups significantly (P

Subject(s)
Choice Behavior , Exercise Therapy/methods , Prescriptions , Walking , Adolescent , Adult , Blood Pressure , Body Composition , Female , Follow-Up Studies , Guidelines as Topic , Humans , Life Style , Male , Middle Aged , Physical Fitness , Surveys and Questionnaires , Time Factors , Walking/psychology
12.
Biochemistry ; 38(8): 2590-600, 1999 Feb 23.
Article in English | MEDLINE | ID: mdl-10029554

ABSTRACT

Reactive intermediates generated by phagocytes damage DNA and may contribute to the link between chronic inflammation and cancer. Myeloperoxidase, a heme protein secreted by activated phagocytes, is a potential catalyst for such reactions. Recent studies demonstrate that this enzyme uses hydrogen peroxide (H2O2) and nitrite (NO2-) to generate reactive nitrogen species which convert tyrosine to 3-nitrotyrosine. We now report that activated human neutrophils use myeloperoxidase, H2O2, and NO2- to nitrate 2'-deoxyguanosine, one of the nucleosides of DNA. Through HPLC, UV/vis spectroscopy, and mass spectrometry, the two major products of this reaction were identified as 8-nitroguanine and 8-nitro-2'-deoxyguanosine. Nitration required each component of the complete enzymatic system and was inhibited by catalase and heme poisons. However, it was independent of chloride ion and little affected by scavengers of hypochlorous acid, suggesting that the reactive agent is a nitrogen dioxide-like species that results from the one-electron oxidation of NO2- by myeloperoxidase. Alternatively, 2'-deoxyguanosine might be oxidized directly by the enzyme to yield a radical species which subsequently reacts with NO2- or NO2* to generate the observed products. Human neutrophils stimulated with phorbol ester also generated 8-nitroguanine and 8-nitro-2'-deoxyguanosine. The reaction required NO2- and was inhibited by catalase and heme poisons, implicating myeloperoxidase in the cell-mediated pathway. These results indicate that human neutrophils use the myeloperoxidase-H2O2-NO2- system to generate reactive species that can nitrate the C-8 position of 2'-deoxyguanosine. Our observations raise the possibility that reactive nitrogen species generated by myeloperoxidase and other peroxidases contribute to nucleobase oxidation and tissue injury at sites of inflammation.


Subject(s)
Deoxyguanosine/analogs & derivatives , Deoxyguanosine/chemistry , Hydrogen Peroxide/chemistry , Neutrophils/metabolism , Nitrites/chemistry , Oxidants/chemistry , Peroxidase/chemistry , Biomarkers/blood , Biomarkers/chemistry , Deoxyguanosine/blood , Guanine/analogs & derivatives , Guanine/blood , HL-60 Cells , Humans , Hydrogen Peroxide/blood , Neutrophil Activation , Nitrates/blood , Nitrites/blood , Nitroso Compounds/blood , Oxidants/blood , Oxidation-Reduction , Peroxidase/blood
13.
EMBO J ; 18(1): 58-64, 1999 Jan 04.
Article in English | MEDLINE | ID: mdl-9878050

ABSTRACT

The F1-ATPase is a multimeric enzyme (alpha3 beta3 gamma delta epsilon) primarily responsible for the synthesis of ATP under aerobic conditions. The entire coding region of each of the genes was deleted separately in yeast, providing five null mutant strains. Strains with a deletion in the genes encoding alpha-, beta-, gamma- or delta-subunits were unable to grow, while the strain with a null mutation in epsilon was able to grow slowly on medium containing glycerol as the carbon source. In addition, strains with a null mutation in gamma or delta became 100% rho0/rho- and the strain with the null mutation in gamma grew much more slowly on medium containing glucose. These additional phenotypes were not observed in strains with the double mutations: Delta alpha Delta gamma, Delta beta Delta gamma, Deltaatp11 Delta gamma, Delta alpha Delta delta, Delta beta Delta delta or Deltaatp11 Delta delta. These results indicate that epsilon is not an essential component of the ATP synthase and that mutations in the genes encoding the alpha- and beta-subunits and in ATP11 are epistatic to null mutations in the genes encoding the gamma- and delta-subunits. These data suggest that the propensity to form rho0/rho- mutations in the gamma and delta null deletion mutant stains and the slow growing phenotypes of the null gamma mutant strain are due to the assembly of F1 deficient in the corresponding subunit. These results have profound implications for the physiology of normal cells.


Subject(s)
Epistasis, Genetic , Gene Deletion , Genes, Fungal , Proton-Translocating ATPases/genetics , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Models, Genetic , Phenotype , Protein Conformation , Proton-Translocating ATPases/chemistry , Saccharomyces cerevisiae/growth & development
15.
Biochem Biophys Res Commun ; 250(2): 335-41, 1998 Sep 18.
Article in English | MEDLINE | ID: mdl-9753630

ABSTRACT

The mutation responsible for the juvenile form of Batten disease was mapped to a single gene, Cln3 (T. J. Lerner et al. (1995) Cell 82:949-957). Yeast Saccharomyces cerevisiae has an open reading frame, BTN1 (YHC3), that encodes the putative homologue of Cln3p. Primary structure comparison indicates that the human Cln3p and yeast Btn1p are 59% similar and 39% identical and they have similar hydropathy profiles. Gene disruption of BTN1 in yeast has no apparent effect on growth or viability of the cells under a variety of conditions. Gene fusion protein constructs of green fluorescent protein (GFP) and Btn1p, with GFP at the amino and carboxyl ends of Btn1p, localize to the vacuole in yeast. These data indicate that BTN1 is a nonessential gene under most growth conditions which functions in the vacuole in yeast Saccharomyces cerevisiae.


Subject(s)
Cyclins , Genes, Fungal , Genome, Fungal , Neuronal Ceroid-Lipofuscinoses/genetics , Saccharomyces cerevisiae Proteins , Amino Acid Sequence , Humans , Membrane Glycoproteins/genetics , Molecular Chaperones/genetics , Molecular Sequence Data , Open Reading Frames/genetics , Saccharomyces cerevisiae/genetics , Sequence Alignment , Sequence Homology, Amino Acid
16.
J Biol Chem ; 272(6): 3520-6, 1997 Feb 07.
Article in English | MEDLINE | ID: mdl-9013599

ABSTRACT

Lipoprotein oxidation has been implicated in the pathogenesis of atherosclerosis. However, the physiologically relevant pathways mediating oxidative damage have not yet been identified. Three potential mechanisms are tyrosyl radical, hydroxyl radical, and redox active metal ions. Tyrosyl radical forms o,o'-dityrosine cross-links in proteins. The highly reactive hydroxyl radical oxidizes phenylalanine residues to o-tyrosine and m-tyrosine. Metal ions oxidize low density lipoprotein (LDL) by poorly understood pathways. To explore the involvement of tyrosyl radical, hydroxyl radical, and metal ions in atherosclerosis, we developed a highly sensitive and quantitative method for measuring levels of o, o'-dityrosine, o-tyrosine, and m-tyrosine in proteins, lipoproteins, and tissue, using stable isotope dilution gas chromatography-mass spectrometry. We showed that o,o'-dityrosine was selectively produced in LDL oxidized with tyrosyl radical. Both o-tyrosine and o, o'-dityrosine were major products when LDL was oxidized with hydroxyl radical. Only o-tyrosine was formed in LDL oxidized with copper. Similar profiles of oxidation products were observed in bovine serum albumin oxidized with the three different systems. Applying these findings to LDL isolated from human atherosclerotic lesions, we detected a 100-fold increase in o,o'-dityrosine levels compared to those in circulating LDL. In striking contrast, levels of o-tyrosine and m-tyrosine were not elevated in LDL isolated from atherosclerotic tissue. Analysis of fatty streaks revealed a similar pattern of oxidation products; compared with normal aortic tissue, there was a selective increase in o,o'-dityrosine with no change in o-tyrosine. The detection of a selective increase of o,o'-dityrosine in LDL isolated from vascular lesions is consistent with the hypothesis that oxidative damage in human atherosclerosis is mediated in part by tyrosyl radical. In contrast, these observations do not support a role for free metal ions as catalysts of LDL oxidation in the artery wall.


Subject(s)
Arteriosclerosis/metabolism , Copper/metabolism , Hydroxyl Radical/metabolism , Lipoproteins, LDL/metabolism , Tyrosine/metabolism , Animals , Aorta/metabolism , Cattle , Endothelium, Vascular/metabolism , Gas Chromatography-Mass Spectrometry , Humans , Mass Spectrometry , Oxidation-Reduction , Peroxidase/metabolism , Phenylalanine/metabolism , Tyrosine/analogs & derivatives
17.
Arch Biochem Biophys ; 337(1): 8-16, 1997 Jan 01.
Article in English | MEDLINE | ID: mdl-8990262

ABSTRACT

The structure/function relationship of oligomycin sensitivity-conferring protein (OSCP), subunit 5 of the mitochondrial ATP synthase, from yeast Saccharomyces cerevisiae has been studied by a combination of genetic and biochemical methods. OSCP was studied by deletion mutagenesis of the N- and C-terminal regions by modifying the gene coding for OSCP. Two deletion mutations were made immediately downstream of the leader peptide of OSCP and five were made at the C-terminus. OSCP was functional with deletions of amino acids 3 to 17 (ND15) and of the last 8 amino acids (CD8), while deletion of amino acids 3 to 31 (ND29) and the last 9 amino acids (CD9) inactivated the ATP synthase, as determined by in vivo analysis. The deletion mutants were expressed in Escherichia coli, purified, and studied by in vitro reconstitution studies. Circular dichroism studies suggested that the mutant proteins, with the possible exception of ND29, were folded in a similar fashion as wild-type OSCP. Mutants ND15 and CD8 were able to reconstitute an oligomycin-sensitive ATPase complex, although not as well as wild-type OSCP, while ND29 and CD9 were completely ineffective. Binding studies of ND29 and CD9 indicate that these mutants in OSCP were unable to bind to the membrane portion of the ATP synthase, F0, and these results were supported by competition binding studies. These results support the hypothesis that the N- and C-terminal regions of subunit 5 interact with F0 and suggest that the central region interacts with F1.


Subject(s)
Adenosine Triphosphatases/chemistry , Carrier Proteins , Membrane Proteins/chemistry , Oligomycins/pharmacology , Proton-Translocating ATPases/chemistry , Amino Acid Sequence , Circular Dichroism , Fungal Proteins/chemistry , Macromolecular Substances , Mitochondrial Proton-Translocating ATPases , Molecular Sequence Data , Protein Structure, Secondary , Saccharomyces cerevisiae/genetics , Sequence Deletion , Structure-Activity Relationship , Uncoupling Agents/pharmacology
18.
Arch Biochem Biophys ; 337(1): 27-33, 1997 Jan 01.
Article in English | MEDLINE | ID: mdl-8990264

ABSTRACT

Residue beta-V198 of the yeast mitchondrial F1-ATPase abuts the P-loop motif and the side chain is within 3.8 A of the nucleotide as shown in the crystal structure of the bovine ATPase [J. P. Abrahams, A. G. W. Leslie, R. Lutter, and J. E. Walker (1984) Nature 370,621-628]. This study has made and analyzed 17 replacements of V198 to understand the importance of the side chain in the nucleotide binding site. In addition, a suppressor of V198S, beta-L390F, was studied in the presence of various replacements at position 198. In vivo and in vitro analyses indicate that the Val side chain is critical for forming a stable and active enzyme. Biochemical analysis of mitochondria isolated from the mutant strains indicates that amino acids with hydrophobic side chains are the most effective replacements. In addition, size is important, but a large side chain can be largely compensated for until the size reaches that of the Phe and Trp. A methyl group is the minimal side chain necessary for function, as the beta-subunit is not stable in vivo with Gly at position 198. These results indicate that V198 forms critical hydrophobic interactions with the adenine ring of the nucleotide.


Subject(s)
Peptides , Proton-Translocating ATPases/chemistry , Adenine/chemistry , Anti-Bacterial Agents/pharmacology , Azides/pharmacology , Binding Sites , Enzyme Inhibitors/pharmacology , Kinetics , Mitochondria/enzymology , Models, Molecular , Mutagenesis, Site-Directed , Oligomycins/pharmacology , Proton-Translocating ATPases/antagonists & inhibitors , Proton-Translocating ATPases/genetics , Saccharomyces cerevisiae/enzymology , Solubility , Structure-Activity Relationship
19.
Free Radic Biol Med ; 23(6): 909-16, 1997.
Article in English | MEDLINE | ID: mdl-9378370

ABSTRACT

Oxidative modification of proteins has been implicated in a variety of processes ranging from atherosclerosis to aging. Identifying the underlying oxidation pathways has proven difficult, however, due to the lack of specific markers for distinct oxidation pathways. Previous in vitro studies demonstrated that 3-chlorotyrosine is a specific product of myeloperoxidase-catalyzed oxidative damage and that the chlorinated amino acid may thus serve as an index of phagocyte-mediated tissue injury in vivo. Here we describe a highly sensitive and specific analytical method for the quantification of 3-chlorotyrosine content of tissues. The assay combines gas chromatography with stable isotope dilution mass spectrometry, and it detects attomole levels of 3-chlorotyrosine in a single determination. Furthermore, the method is highly reproducible, with inter- and intra-sample coefficients of variance of < 3%. The specificity, sensitivity, and reproducibility of 3-chlorotyrosine determination should make this method useful for exploring the role of myeloperoxidase in catalyzing oxidative reactions in vivo.


Subject(s)
Chlorine/metabolism , Peroxidase/metabolism , Tyrosine/analogs & derivatives , Analysis of Variance , Aorta , Arteriosclerosis/enzymology , Arteriosclerosis/metabolism , Biomarkers/analysis , Calibration , Carbon , Carbon Isotopes , Catalysis , Female , Gas Chromatography-Mass Spectrometry , Humans , Hypochlorous Acid , Inflammation/enzymology , Inflammation/metabolism , Lipoproteins, LDL/metabolism , Male , Sensitivity and Specificity , Tyrosine/analysis
20.
J Clin Invest ; 98(6): 1283-9, 1996 Sep 15.
Article in English | MEDLINE | ID: mdl-8823292

ABSTRACT

Reactive oxidants generated by phagocytes are of central importance in host defenses, tumor surveillance, and inflammation. One important pathway involves the generation of potent halogenating agents by the myeloperoxidase-hydrogen peroxide-chloride system. The chlorinating intermediate in these reactions is generally believed to be HOCl or its conjugate base, ClO-. However, HOCl is also in equilibrium with Cl2, raising the possibility that Cl2 executes oxidation/ halogenation reactions that have previously been attributed to HOCl/ClO-. In this study gas chromatography-mass spectrometric analysis of head space gas revealed that the complete myeloperoxidase-hydrogen peroxide-chloride system generated Cl2. In vitro studies demonstrated that chlorination of the aromatic ring of free L-tyrosine was mediated by Cl2 and not by HOCl/ClO-. Thus, 3-chlorotyrosine serves as a specific marker for Cl2-dependent oxidation of free L-tyrosine. Phagocytosis of L-tyrosine encapsulated in immunoglobulin- and complement-coated sheep red blood cells resulted in the generation of 3-chlorotyrosine. Moreover, activation of human neutrophils adherent to a L-tyrosine coated glass surface also stimulated 3-chlorotyrosine formation. Thus, in two independent models of phagocytosis human neutrophils convert L-tyrosine to 3-chlorotyrosine, indicating that a Cl2-like oxidant is generated in the phagolysosome. In both models, synthesis of 3-chlorotyrosine was inhibited by heme poisons and the peroxide scavenger catalase, implicating the myeloperoxidase-hydrogen peroxide system in the reaction. Collectively, these results demonstrate that myeloperoxidase generates Cl2 and that human neutrophils use an oxidant with characteristics identical to those of Cl2 during phagocytosis. Moreover, our observations suggest that phagocytes exploit the chlorinating properties of Cl2 to execute oxidative and cytotoxic reactions at sites of inflammation and vascular disease.


Subject(s)
Chlorine/metabolism , Neutrophils/immunology , Neutrophils/metabolism , Phagocytosis , Gas Chromatography-Mass Spectrometry , Humans , Inflammation/metabolism , Leukocytes/metabolism , Neutrophil Activation , Oxidation-Reduction , Peroxidase/metabolism , Phagosomes/metabolism , Tyrosine/analogs & derivatives , Tyrosine/biosynthesis , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...